NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $8.91 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$8.91 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About InnovAge Stock (NASDAQ:INNV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InnovAge alerts:Sign Up Key Stats Today's Range$8.24▼$9.3050-Day Range$8.80▼$10.9252-Week Range$4.70▼$12.64Volume747,566 shsAverage Volume516,261 shsMarket Capitalization$1.22 billionP/E Ratio148.50Dividend YieldN/APrice Target$10.50Consensus RatingModerate Buy Company Overview InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home. The company operates PACE programs in Colorado, California, New Mexico, Pennsylvania and Virginia. Its model is designed to bring medical and supportive services together around each participant’s needs, helping eligible older adults remain in their homes and communities.AI Generated. May Contain Errors. Read More InnovAge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreINNV MarketRank™: 3.37965498357 of 5 starsInnovAge scored higher than 68% of companies evaluated by MarketBeat, and ranked 217th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingInnovAge has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialInnovAge has a consensus price target of $10.50, representing about 17.8% upside from its current price of $8.91.Amount of Analyst CoverageInnovAge has only been the subject of 3 research reports in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.36% Earnings GrowthEarnings for InnovAge are expected to grow by 11.36% in the coming year, from $0.44 to $0.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is 148.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.64.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is 148.50, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.77.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 4.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.66% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 1.44, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InnovAge has recently decreased by 22.08%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.54 News SentimentInnovAge has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for InnovAge this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added InnovAge to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $120,489,535.00 in company stock.Percentage Held by Insiders1.10% of the stock of InnovAge is held by insiders.Percentage Held by Institutions12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INNV Stock News HeadlinesInnovAge Resolves Federal, State Claims Over Historical PracticesNovember 18 at 6:36 PM | marketscreener.comMInnovAge Holding Corp. Announces $37 Million Settlement With U.S. Department of Justice and Participating StatesNovember 18 at 4:31 PM | quiverquant.comQThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 19 at 1:00 AM | Digest Publishing (Ad)InnovAge Holding Corp. Resolves Civil Matter with U.S. Department of Justice & Participating StatesNovember 18 at 4:05 PM | globenewswire.comInnovAge Holding to Pay $36 Million to Resolve Allegations of False Claims Act, State Law Violations -- UpdateNovember 17 at 2:26 PM | marketscreener.comMInnovAge Holding to Pay $36 Million to Resolve Allegations of False Claims Act, State Law ViolationsNovember 17 at 12:22 PM | marketscreener.comMInnovAge (NASDAQ:INNV) Insider Nicole Damato Sells 3,402 Shares of Company StockOctober 27, 2026 | insidertrades.comInnovAge (NASDAQ:INNV) Major Shareholder Sells $13,875,000.00 in StockOctober 24, 2026 | insidertrades.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $5.19 at the start of the year. Since then, INNV stock has increased by 71.7% and is now trading at $8.91. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) announced its earnings results on Tuesday, November, 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.05. The business had revenue of $264.76 million for the quarter, compared to analyst estimates of $257.23 million. InnovAge had a net margin of 0.88% and a trailing twelve-month return on equity of 3.63%. Read the conference call transcript. When did InnovAge IPO? InnovAge (INNV) raised $342 million in an IPO on Thursday, March 4th 2021. The company issued 16,666,667 shares at a price of $20.00-$21.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. Who are InnovAge's major shareholders? InnovAge's top institutional shareholders include Ghisallo Capital Management LLC (0.50%), Goldman Sachs Group Inc. (0.49%), State Street Corp (0.34%) and Marshall Wace LLP (0.30%). Insiders that own company stock include Carson Anderson & Stow Welsh, Aggregator Lp Ignite, Nicole Damato, Michael Anthony Scarbrough, Richard C Zoretic and Richard C Zoretic. View institutional ownership trends. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Walt Disney (DIS), NVIDIA (NVDA), Visa (V), Energy Transfer (ET), American International Group (AIG), Blackstone (BX) and Enterprise Products Partners (EPD). Company Calendar Last Earnings11/03/2026Today11/19/2026Next Earnings (Estimated)2/02/2027Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 INNV's financial health is in the Green zone, according to TradeSmith. INNV has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:INNV Previous SymbolOTCMKTS:INNV CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,500Year Founded1990Price Target and Rating Average Price Target for InnovAge$10.50 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+17.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio148.50 Forward P/E Ratio18.18 P/E GrowthN/ANet Income-$2.54 million Net Margins0.88% Pretax Margin1.22% Return on Equity3.63% Return on Assets1.64% Debt Debt-to-Equity Ratio0.20 Current Ratio1.16 Quick Ratio1.16 Sales & Book Value Annual Sales$989.71 million Price / Sales1.23 Cash Flow$0.14 per share Price / Cash Flow62.42 Book Value$1.89 per share Price / Book4.71Miscellaneous Outstanding Shares136,460,000Free Float134,956,000Market Cap$1.22 billion OptionableOptionable Beta0.16 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:INNV) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.